{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:26:47Z","timestamp":1783780007810,"version":"3.55.0"},"reference-count":29,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.6926-25","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:08:54Z","timestamp":1773698934000},"source":"Crossref","is-referenced-by-count":1,"title":["A Single-Kindred Cluster of Val122Ile Transthyretin Amyloid Cardiomyopathy: Subclinical Case Series of Three Japanese Patients"],"prefix":"10.2169","author":[{"given":"Toshihiro","family":"Tsuruda","sequence":"first","affiliation":[{"name":"Cardiorenal Research Laboratory, Department of Hemo-Vascular Advanced Medicine, Faculty of Medicine, University of Miyazaki, Japan"},{"name":"Division of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narukuni","family":"Kodama","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Tanahashi","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Suiko","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinuko","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichi","family":"Komaki","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Moribayashi","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiharu","family":"Terakawa","sequence":"additional","affiliation":[{"name":"Division of Clinical Genetics, Faculty of Medicine, University of Miyazaki Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minayo","family":"Iwai","sequence":"additional","affiliation":[{"name":"Division of Clinical Genetics, Faculty of Medicine, University of Miyazaki Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Sakai","sequence":"additional","affiliation":[{"name":"Division of Respirology, Rheumatology, Infectious Diseases and Neurology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Shiomi","sequence":"additional","affiliation":[{"name":"Division of Respirology, Rheumatology, Infectious Diseases and Neurology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamasa","family":"Terada","sequence":"additional","affiliation":[{"name":"Department of Radiology, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nakada","sequence":"additional","affiliation":[{"name":"Department of Radiology, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Ogata","sequence":"additional","affiliation":[{"name":"Heart Center, Faculty of Medicine, University of Miyazaki Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyo","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Heart Center, Faculty of Medicine, University of Miyazaki Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Pathology Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Iida","sequence":"additional","affiliation":[{"name":"Iida Orthopaedic Clinic Iida Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunosuke","family":"Matsuura","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kaikita","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Damrauer SM, Chaudhary K, Cho JH, et al. Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic\/Latino Ancestry. JAMA 322: 2191-2202, 2019.","DOI":"10.1001\/jama.2019.17935"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Nomura T, Misumi Y, Tasaki M, et al. Genetic and clinical features of hereditary transthyretin amyloidosis: a decade of experience at a Japanese referral center. Orphanet J Rare Dis 20: 474, 2025.","DOI":"10.1186\/s13023-025-04006-6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Chandrashekar P, Alhuneafat L, Mannello M, et al. Prevalence and Outcomes of p.Val142Ile TTR Amyloidosis Cardiomyopathy: A Systematic Review. Circ: Genom Precis Med 14: e003356, 2021.","DOI":"10.1161\/CIRCGEN.121.003356"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Buxbaum JN, Ruberg FL. Transthyretin V122I (pV142I) * cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans. Genet Med 19: 733-742, 2017.","DOI":"10.1038\/gim.2016.200"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Carry BJ, Young K, Fielden S, et al. Genomic Screening for Pathogenic Transthyretin Variants Finds Evidence of Underdiagnosed Amyloid Cardiomyopathy From Health Records. JACC: CardioOncol 3: 550-561, 2021.","DOI":"10.1016\/j.jaccao.2021.07.002"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Naito T, Nakamura K, Abe Y, et al. Prevalence of transthyretin amyloidosis among heart failure patients with preserved ejection fraction in Japan. ESC Heart Fail 10: 1896-1906, 2023.","DOI":"10.1002\/ehf2.14364"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yoshinaga T, Yazaki M, Ohno M, et al. Cardiac Amyloidosis Associated With Amyloidogenic Transthyretin V122I Variant in an Elderly Japanese Woman. Circ J 81: 893-894, 2017.","DOI":"10.1253\/circj.CJ-16-1202"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Nehashi T, Oikawa M, Amami K, et al. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant. Int Heart J 60: 1441-1443, 2019.","DOI":"10.1536\/ihj.19-134"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ono R, Takahashi H, Sato T, et al. A case of cardiac amyloidosis in an elderly Japanese patient with amyloidogenic transthyretin Val122Ile variant. J Cardiol Cases 22: 221-225, 2020.","DOI":"10.1016\/j.jccase.2020.07.010"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Phelan D, Collier P, Thavendiranathan P, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart 98: 1442-1448, 2012.","DOI":"10.1136\/heartjnl-2012-302353"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Tsuruda T, Nakada H, Yamamura Y, et al. Basal inferoseptal segment is highly susceptible to deformation in the clinical spectrum of transthyretin-derived amyloid cardiomyopathy. Eur Heart J Open 4: oeae076, 2024.","DOI":"10.1093\/ehjopen\/oeae076"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Trachtenberg BH, Shah SK, Nussbaum RL, et al. Presence of the V122I Variant of Hereditary Transthyretin-Mediated Amyloidosis Among Self-Reported White Individuals in a Sponsored Genetic Testing Program. Circ: Genom Precis Med 14: e003466, 2021.","DOI":"10.1161\/CIRCGEN.121.003466"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Shah KB, Mankad AK, Castano A, et al. Transthyretin Cardiac Amyloidosis in Black Americans. Circ Heart Fail 9: e002558, 2016.","DOI":"10.1161\/CIRCHEARTFAILURE.115.002558"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Madhani A, Sabogal N, Massillon D, et al. Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study. J Am Heart Assoc 12: e028973, 2023.","DOI":"10.1161\/JAHA.122.028973"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Carvalho E, Dias A, Coelho T, et al. Hereditary transthyretin amyloidosis: a myriad of factors that influence phenotypic variability. Journal of Neurology 271: 5746-5761, 2024.","DOI":"10.1007\/s00415-024-12509-8"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Pathak GA, Wendt FR, De Lillo A, et al. Epigenomic Profiles of African-American Transthyretin Val122Ile Carriers Reveals Putatively Dysregulated Amyloid Mechanisms. Circ: Genom Precis Med 14: e003011, 2021.","DOI":"10.1161\/CIRCGEN.120.003011"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kasiakogias A, Rosei EA, Camafort M, et al. Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension. J Hypertens 39: 1522-1545, 2021.","DOI":"10.1097\/HJH.0000000000002910"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Sperry BW, Reyes BA, Ikram A, et al. Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release. J Am Coll Cardiol 72: 2040-2050, 2018.","DOI":"10.1016\/j.jacc.2018.07.092"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Westin O, Fosb\u00f8l EL, Maurer MS, et al. Screening for Cardiac Amyloidosis 5 to 15 Years After Surgery for Bilateral Carpal Tunnel Syndrome. J Am Coll Cardiol 80: 967-977, 2022.","DOI":"10.1016\/j.jacc.2022.06.026"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Pimenta S, Santos L, Martins A, et al. Screening for Cardiac Amyloidosis When Conducting Carpal Tunnel Surgery. J Clin Med 14: 3710, 2025.","DOI":"10.3390\/jcm14113710"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Pucci A, Aimo A, Musetti V, et al. Amyloid Deposits and Fibrosis on Left Ventricular Endomyocardial Biopsy Correlate With Extracellular Volume in Cardiac Amyloidosis. J Am Heart Assoc 10: e020358, 2021.","DOI":"10.1161\/JAHA.120.020358"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Vergaro G, Aimo A, Rapezzi C, et al. Atrial amyloidosis: mechanisms and clinical manifestations. Eur J Heart Fail 24: 2019-2028, 2022.","DOI":"10.1002\/ejhf.2650"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ichimata S, Hata Y, Yoshida K, Hirono K, Nishida N. Distinctive Deposition Patterns of Sporadic Transthyretin-Derived Amyloidosis in the Atria: A Forensic Autopsy-Based Study. Int J Mol Sci 25: 8176, 2024.","DOI":"10.3390\/ijms25158176"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kim JY, Hong YJ, Han K, et al. Regional Amyloid Burden Differences Evaluated Using Quantitative Cardiac MRI in Patients with Cardiac Amyloidosis. Korean J Radiol 22: 880-889, 2021.","DOI":"10.3348\/kjr.2020.0579"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Liu Y, Zhu J, Chen M, et al. 3.0T cardiac magnetic resonance quantification of native T1 and myocardial extracellular volume for the diagnosis of late gadolinium enhancement-negative cardiac amyloidosis. Ann Transl Med 10: 794, 2022.","DOI":"10.21037\/atm-22-3251"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Bulluck H, Maestrini V, Rosmini S, et al. Myocardial T1 Mapping- Hope or Hype? -. Circ J 79: 487-494, 2015.","DOI":"10.1253\/circj.CJ-15-0054"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Maurer MS, Schwartz JH, Gundapaneni B, et al. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N Engl J Med 379: 1007-1016, 2018.","DOI":"10.1056\/NEJMoa1805689"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Gillmore JD, Judge DP, Cappelli F, et al. Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy. N Eng J Med 390: 132-142, 2024.","DOI":"10.1056\/NEJMoa2305434"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Fontana M, Berk JL, Gillmore JD, et al. Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy. N Eng J Med 392: 33-44, 2025.","DOI":"10.1056\/NEJMc2501792"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_6926-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T03:34:08Z","timestamp":1774064048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_6926-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":29,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6926-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"6926-25"}}